Peter Durcan, PhD

Peter Durcan, PhD

Co-founder and Chief Scientific Officer

Dr Peter Durcan has been involved in molecular biology research for the past 15 years. During his time in academia he has studied at a variety of universities in many countries including:
Ireland: University of Limerick (BSc)
Finland: University of Jyvaskyla (Erasmus study period)
Scotland: University of Aberdeen (MSc)
England: Manchester Metropolitan University (PhD)
South Africa: University of Stellenbosch (Post Doc Fellowship).

In addition to his time at academic institutes Peter has also spent time conducting research at the world renowned gene therapy centre, Genethon in France.

Peter has spent a significant amount of his research career investigating the molecular mechanism regulating mammalian somatic cell fusion, a process that involves the merger of two cells into one. During his research to date he has co-authored internationally peer reviewed papers on the discovery of previously unknown variants of genes in human and mouse skeletal muscle. Additionally Peter has also co-authored internationally peer reviewed papers on an interesting form of intercellular communication involving nanosized particles termed extracellular Vesicles.

Peter’s Publications:

Al-Shanti, N., Durcan, P., Al-Dabbagh, S., Dimchev, G.A., and Stewart, C.E. (2014). Activated Lymphocytes Secretome Inhibits Differentiation and Induces Proliferation of C2C12 Myoblasts. Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 33, 117–128.

Durcan, P., Conradie, J.D., Van deVyver, M., and Myburgh, K. (2014). Identification of novel Kirrel3 gene splice variants in adult human skeletal muscle. BMC Physiol. 14, 11.

Durcan, P.J., Al-Shanti, N., and Stewart, C.E. (2013). Identification and characterization of novel Kirrel isoform during myogenesis. Physiol. Rep